Seroprevalence of Crimean Congo Hemorrhagic Fever Virus in Occupational Settings: Systematic Review and Meta-Analysis

Abstract

Crimean Congo Hemorrhagic Fever (CCHF) Virus can cause a serious human disease, with the case fatality ratio previously estimated to be 30–40%. Our study summarized seroprevalence data from occupational settings, focusing on the following occupational groups: animal handlers, abattoir workers, farmers, healthcare workers, veterinarians, rangers, and hunters. Systematic research was performed on three databases (PubMed, EMBASE, MedRxiv), and all studies reporting seroprevalence rates (IgG-positive status) for CCHF virus were retrieved and their results were reported, summarized, and compared. We identified a total of 33 articles, including a total of 20,195 samples, i.e., 13,197 workers from index occupational groups and 6998 individuals from the general population. Pooled seroprevalence rates ranged from 4.751% (95% confidence intervals (95% CI) 1.834 to 11.702) among animal handlers, to 3.403% (95% CI 2.44 to 3.932) for farmers, 2.737% (95% CI 0.896 to 8.054) among rangers and hunters, 1.900% (95% CI 0.738 to 4.808) for abattoir workers, and 0.644% (95% CI 0.223–1.849) for healthcare workers, with the lowest estimate found in veterinarians (0.283%, 95% CI 0.040–1.977). Seroprevalence rates for abattoir workers (odds ratio (OR) 4.198, 95% CI 1.060–16.464), animal handlers (OR 2.399, 95% CI 1.318–4.369), and farmers (OR 2.280, 95% CI 1.419 to 3.662) largely exceeded the official notification rates for CCHF in the general population. CCHF is reasonably underreported, and pooled estimates stress the importance of improving the adherence to personal protective equipment use and appropriate preventive habits.

Tick-Borne Encephalitis Virus Vaccination among Tourists in a High-Prevalence Area (Italy, 2023): A Cross-Sectional Study

“…Although avoiding tick bites remains the most effective strategy for preventing the entirety of tick-borne diseases (e.g., Lyme disease, babesiosis, ehrlichiosis, Rocky Mountain spotted fever, anaplasmosis, or Crimean Congo hemorrhagic fever) [42][43][44], the efficacy of TBE vaccines has been well-documented [16,27,45,46]. Therefore, a rational public health approach for achieving the control of TBE in high-risk areas [16,18,27] cannot rule out interventions aimed at improving vaccination rates [24,47].…”